Salt Lake City, Utah., June 18, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) today announced that its Board of Directors has initiated a process to explore potential strategic options for the Company.

Nearly one-third (31%) of OT organizations reported more than six intrusions in the last year, up from 11% the year before

Survey shows 75% of beachgoers typically use their phone at the beach, just under two thirds who bring their phone say they’ve used it for work

Current CFO, Michael Vander Hoek, transitions to full-time Vice President, Regulatory

The homebuilder was also recognized for its philanthropic efforts and commitment to sustainability

FORM 8.3

Advances plan to acquire critical asset for technology and defense industries in the western world, further de-risking transaction

FORM 8.3

Westford, USA, June 18, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the cancer gene therapy market will attain a value of USD 12.63 billion by 2031, with a CAGR of 20.42% during the forecast period (2024-2031). Evolution in genetic research and therapeutic approaches have fostered a powerful growth in the cancer gene therapy market. Gene therapies enable targeted interventions at the genetic level, presenting a huge potential in cancer treatments. Hence, this market encounters severe push from the upward trajectory of global cancer incidence and growing demand for personalized medicine, to use gene therapy as a promising treatment path for cancer patients. On top of that, intensive research and development activities, positive governmental policies, and research institutions in collaboration with pharmaceutical firms have worked out to further expand the market. 

First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter

Westford, USA, June 18, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Carbon Capture, Utilization and Storage Market will attain a value of USD 6.16 billion by 2031, with a CAGR of 11.8% during the forecast period (2024-2031). Carbon capture and storage or CCS is a relatively new technology, that has come forward due to increasing awareness related to the growing   environmental impact of carbon emissions. It can minimize CO2 emissions significantly as well as help us to meet demanding climate goals. As a result, it is promoted by governments through several demonstration projects in different industries around the world. CCS is being viewed as a critical technology which can help us in wide-scale adoption of renewable energy sources such as wind and solar, without which fossil fuels will continue to dominate energy generation and consumption patterns. 

                                                        FORM 8.3

Seasoned turnaround advisor and corporate attorney brings over 25 years leadership experience in the public markets

WARREN, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced its expected addition to the broad-market Russell 3000^® and Russell 2000^® Indexes at the conclusion of the 2024 Russell U.S. indexes annual reconstitution, effective at the open of U.S. equity markets on Monday, July 1, according to a preliminary list of additions posted Friday, May 24, 2024.

VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) -- Prosper Gold Corp. ("Prosper Gold" or the "Company") (TSXV:PGX) is pleased to announce that crews and equipment have been mobilized to initiate a property-wide ZTEM geophysical survey at the Company’s Cyprus Project in north-central British Columbia, Canada. The Cyprus Project is a district-scale porphyry copper-gold project with several historically defined copper ± gold porphyry prospects and significant drill results including 138.2 metres at 0.55% copper.

Expands reach of authID’s next-gen biometric identity platform with integration to Syntrove’s risk and fraud technology platform

SAN FRANCISCO, June 18, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced it will host the second part of its virtual KOL investor event series on Wednesday, June 26, 2024 at 10:00 AM ET. To register, click here.

New analysis of the pivotal Phase 3 SOLOIST-WHF trial demonstrates INPEFA cost-effectiveness

MALVERN, Pa., June 18, 2024 (GLOBE NEWSWIRE) -- via IBN -- Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (AD) and Parkinson’s disease (PD), is pleased to announce that it has been selected to present the data from its latest Alzheimer’s study in an extended 45-minute session at the Alzheimer’s Association International Conference® 2024 (AAIC®). The conference will take place from July 28 to August 1 in Philadelphia, USA, and online.